Literature DB >> 21272011

The history and current state of drug abuse in Japan.

Kiyoshi Wada1.   

Abstract

Drug abuse in Japan began after World War II and has been characterized by three epidemics of methamphetamine abuse; in addition, solvent abuse has been prominent for a long time. Since 1995, with the beginning of the third epidemic of methamphetamine abuse, drug abuse or dependence in Japan changed, with a marked decrease in solvent abuse, stabilization of methamphetamine abuse, an increase in the abuse of such drugs as cannabis or 3,4-methylenedioxymethamphetamine (which do not have high potential of causing drug-induced psychosis), and the emergence of designer drugs. Furthermore, the abuse of medical drugs such as Ritalin became a major issue in 2007. These changes reveal an increase in the abuse of drugs that do not as easily produce a psychotic state, underlain with a shift from personal conduct that leads to arrest to conduct that does not. Japan, therefore, needs to deal with drug abuse and dependence using not only a medical model, but also a criminal model as well.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21272011     DOI: 10.1111/j.1749-6632.2010.05914.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  Current status of substance abuse and HIV infection in Japan.

Authors:  Kiyoshi Wada; Masahiko Funada; Takuya Shimane
Journal:  J Food Drug Anal       Date:  2013-12       Impact factor: 6.079

2.  Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.

Authors:  Takeshi Nishijima; Hiroyuki Gatanaga; Hirokazu Komatsu; Misao Takano; Miwa Ogane; Kazuko Ikeda; Shinichi Oka
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

3.  High prevalence of illicit drug use in men who have sex with men with HIV-1 infection in Japan.

Authors:  Takeshi Nishijima; Hiroyuki Gatanaga; Hirokazu Komatsu; Misao Takano; Miwa Ogane; Kazuko Ikeda; Shinichi Oka
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

4.  Reluctance to care for patients with HIV or hepatitis B / C in Japan.

Authors:  Koji Wada; Derek R Smith; Tomohiro Ishimaru
Journal:  BMC Pregnancy Childbirth       Date:  2016-02-05       Impact factor: 3.007

5.  High prevalence of quasi-legal psychoactive substance use among male patients in HIV care in Japan: a cross-sectional study.

Authors:  Kanna Hayashi; Chihiro Wakabayashi; Yuzuru Ikushima; Masayoshi Tarui
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-02-23

6.  Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use.

Authors:  Sayaka Nagasawa; Hisako Saitoh; Shiori Kasahara; Fumiko Chiba; Suguru Torimitsu; Hiroko Abe; Daisuke Yajima; Hirotaro Iwase
Journal:  Sci Rep       Date:  2018-05-31       Impact factor: 4.379

7.  Analysis of psychotropic drug-related deaths in south Osaka.

Authors:  Naoto Tani; Tomoya Ikeda; Tomomi Michiue; Shigeki Oritani; Fumiya Morioka; Takaki Ishikawa
Journal:  Subst Abuse Rehabil       Date:  2018-09-24

8.  Web-Based Cognitive Behavioral Relapse Prevention Program With Tailored Feedback for People With Methamphetamine and Other Drug Use Problems: Development and Usability Study.

Authors:  Ayumi Takano; Yuki Miyamoto; Norito Kawakami; Toshihiko Matsumoto
Journal:  JMIR Ment Health       Date:  2016-01-06

9.  Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan.

Authors:  Ayumi Takano; Yuki Miyamoto; Norito Kawakami; Toshihiko Matsumoto; Tomohiro Shinozaki; Takashi Sugimoto
Journal:  BMC Psychiatry       Date:  2016-04-04       Impact factor: 3.630

10.  Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014.

Authors:  Ling-Yi Feng; Wen-Jing Yu; Wei-Ting Chang; Eunyoung Han; Heesun Chung; Jih-Heng Li
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-09-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.